Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors : Data from the EuroSpA collaboration

Ørnbjerg, Lykke M.Linde, LouiseGeorgiadis, StylianosRasmussen, Simon H.Lindström, UlfAskling, JohanMichelsen, BrigitteGiuseppe, Daniela DiWallman, Johan K.Pavelka, KarelZávada, JakubNissen, Michael J.Jones, Gareth T.Relas, HeikkiPirilä, LauraTomšič, MatijaRotar, ZigaGeirsson, Arni JonGudbjornsson, BjornKristianslund, Eirik K.van sder Horst-Bruinsma, IreneLoft, Anne GitteLaas, KarinIannone, FlorenzoCorrado, AddolorataCiurea, AdrianSantos, Maria J.Santos, HelenaCodreanu, CatalinAkkoc, NurullahGunduz, Ozgul S.Glintborg, BenteØstergaard, MikkelHetland, Merete Lund2023-04-102023-04-102022-10-01Ørnbjerg, L M, Linde, L, Georgiadis, S, Rasmussen, S H, Lindström, U, Askling, J, Michelsen, B, Giuseppe, D D, Wallman, J K, Pavelka, K, Závada, J, Nissen, M J, Jones, G T, Relas, H, Pirilä, L, Tomšič, M, Rotar, Z, Geirsson, A J, Gudbjornsson, B, Kristianslund, E K, van sder Horst-Bruinsma, I, Loft, A G, Laas, K, Iannone, F, Corrado, A, Ciurea, A, Santos, M J, Santos, H, Codreanu, C, Akkoc, N, Gunduz, O S, Glintborg, B, Østergaard, M & Hetland, M L 2022, 'Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors : Data from the EuroSpA collaboration', Seminars in arthritis and rheumatism, vol. 56, 152081. https://doi.org/10.1016/j.semarthrit.2022.152081, https://doi.org/10.1016/j.semarthrit.2022.1521410049-0172ORCID: /0000-0003-0016-7591/work/132961195https://hdl.handle.net/2164/20454Funding Information This work was supported by Novartis Pharma AG . Acknowledgments The EuroSpA Research Collaboration Network was financially supported by Novartis Pharma AG. Novartis had no influence on the data collection, statistical analyses, manuscript preparation or decision to submit the manuscript. Professor Gary Macfarlane (University of Aberdeen) is Chief Investigator of BSRBR-AS and facilitated access to the UK data used in this study. Corrigendum to ‘Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: data from the EuroSpA collaboration’ [Seminars in Arthritis and Rheumatism 56 (2022) 1-13/152081] https://doi.org/10.1016/j.semarthrit.2022.15214113174003engAnkylosing spondylitis disease activity scoreAxial spondyloarthritisPredictorsTNF-inhibitorsR MedicineRheumatologyAnesthesiology and Pain MedicineImmunology and AllergySupplementary DataRPredictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors : Data from the EuroSpA collaborationJournal article10.1016/j.semarthrit.2022.152081http://www.scopus.com/inward/record.url?scp=85135923596&partnerID=8YFLogxK56